Insiders Trades

★ Sign in to follow

PW

Peter Winston Lewis

RepliCel Life Sciences Inc.

Cumul. flow

Total declarations

15

Company

1

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 05 Dec 2024 for RepliCel Life Sciences Inc..

Insider track record

Disclosed buys

0

Disclosed sells

0

Signal history

Peter Winston Lewis: trading record in brief

Peter Winston Lewis appears in our data through filings on RepliCel Life Sciences Inc. shares, published by SEDI. Over a trading history stretching from 27 May 2011 to 2 December 2024, the count stands at 15 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 5 December 2024, reports a transaction in RepliCel Life Sciences Inc. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Peter Winston Lewis

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

RepliCel Life Sciences Inc. (CA)

Declarations15 total

●

Peter Winston Lewis

4 - Director of IssuerExecutives2 Dec 2024RepliCel Life Sciences Inc.

0SEDI

37,500 sharesConvertible Preferred Shares Class A Preference SharesTSXSEDI:4412902

●

Peter Winston Lewis

4 - Director of IssuerExecutives2 Dec 2024RepliCel Life Sciences Inc.

0SEDI

277,500 sharesCommon SharesTSXSEDI:4412907

●

Peter Winston Lewis

4 - Director of IssuerExecutives1 Feb 2023RepliCel Life Sciences Inc.

1,838 CAD15SEDI

17,500 shares@ CA$0.1051.8% of flowCommon SharesTSXSEDI:4071660

●

Peter Winston Lewis

4 - Director of IssuerExecutives17 Jan 2023RepliCel Life Sciences Inc.

26,750 CAD16SEDI

297,222 shares@ CA$0.0926.6% of flowCommon SharesTSXSEDI:4064513

●

Peter Winston Lewis

4 - Director of IssuerExecutives30 Dec 2022RepliCel Life Sciences Inc.

10,000 CAD12SEDI

100,000 shares@ CA$0.1013.9% of flowCommon SharesTSXSEDI:4053799

●

Peter Winston Lewis

4 - Director of IssuerExecutives2 Jun 2021RepliCel Life Sciences Inc.

10,750 CAD15SEDI

27,922 shares@ CA$0.38517.1% of flowCommon SharesTSXSEDI:3756343

●

Peter Winston Lewis

4 - Director of IssuerExecutives27 May 2021RepliCel Life Sciences Inc.

0SEDI

4,355 sharesCommon SharesTSXSEDI:3755277

●

Peter Winston Lewis

4 - Director of IssuerExecutives27 May 2011RepliCel Life Sciences Inc.

0SEDI

Common SharesTSXSEDI:3755275

●

Peter Winston Lewis

4 - Director of IssuerExecutives30 Apr 2021RepliCel Life Sciences Inc.

10,750 CAD13SEDI

27,922 shares@ CA$0.38516.9% of flowCommon SharesTSXSEDI:3737239

●

Peter Winston Lewis

4 - Director of IssuerExecutives14 Aug 2020RepliCel Life Sciences Inc.

13,750 CAD16SEDI

76,389 shares@ CA$0.1811.3% of flowCommon SharesTSXSEDI:3590681

●

Peter Winston Lewis

4 - Director of IssuerExecutives30 Oct 2019RepliCel Life Sciences Inc.

9,750 CAD17SEDI

34,821 shares@ CA$0.2839.4% of flowCommon SharesTSXSEDI:3443740

●

Peter Winston Lewis

4 - Director of IssuerExecutives27 May 2011RepliCel Life Sciences Inc.

0SEDI

Convertible Preferred Shares Class A Preference SharesTSXSEDI:3424491

●

Peter Winston Lewis

4 - Director of IssuerExecutives10 Sept 2019RepliCel Life Sciences Inc.

15,000 CAD0SEDI

37,500 shares@ CA$0.4060.6% of flowConvertible Preferred Shares Class A Preference SharesTSXSEDI:3424493

●

Peter Winston Lewis

4 - Director of IssuerExecutives15 Jan 2019RepliCel Life Sciences Inc.

17,000 CAD14SEDI

35,789 shares@ CA$0.47526.1% of flowCommon SharesTSXSEDI:3303055

●

Peter Winston Lewis

4 - Director of IssuerExecutives10 Aug 2016RepliCel Life Sciences Inc.

0SEDI

45,000 sharesCommon SharesTSXSEDI:3301688

15 of 15 declarations